Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-2175Fax+1 617-632-3479
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2015 - 2019- Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2015
University of Rochester School of Medicine and DentistryClass of 2013
Certifications & Licensure
CT State Medical License 2022 - 2025
MA State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsDisruption of cellular plasticity by repeat RNAs in human pancreatic cancer.Eunae You, Patrick Danaher, Chenyue Lu, Siyu Sun, Luli Zou
Cell. 2024-12-12 - 1 citationsNon-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses.Shaobo Yang, Michal Sheffer, Isabel E Kaplan, Zongqi Wang, Mubin Tarannum
Nature Biotechnology. 2024-10-04 - 2 citationsCAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer.Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, Grace Birch, Yasmin Z Abdulhamid
Science Advances. 2024-07-12
Press Mentions
First Clinical Trial of “Memory Like” Natural Killer Cells in Ovarian Cancer Opens at Dana-FarberNovember 15th, 2024- Shop TalkOctober 5th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
